sk&f-38393 has been researched along with Bradykinesia in 1 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldberg, MS | 1 |
Pisani, A | 1 |
Haburcak, M | 1 |
Vortherms, TA | 1 |
Kitada, T | 1 |
Costa, C | 1 |
Tong, Y | 1 |
Martella, G | 1 |
Tscherter, A | 1 |
Martins, A | 1 |
Bernardi, G | 1 |
Roth, BL | 1 |
Pothos, EN | 1 |
Calabresi, P | 1 |
Shen, J | 1 |
1 other study available for sk&f-38393 and Bradykinesia
Article | Year |
---|---|
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Behavior, Animal; | 2005 |